In addition, we separately analyzed the relationship between KRT17 expression and prognosis in the various molecular subtypes of BC, especially those with different HER2 and ER profiles according to patients’ survival analysis (Supplementary Figure S2A–C). Here, KRT17 is linked to breast cancer.